Literature DB >> 32141744

Lipid-Lowering Effects and Intestinal Transport of Polyphenol Extract from Digested Buckwheat in Caco-2/HepG2 Coculture Models.

Yijun Yao1,2, Feiran Xu1, Xingrong Ju1,2, Zhifang Li2, Lifeng Wang2.   

Abstract

Polyphenol extracts derived from gastrointestinal digestates of buckwheat (Fagopyrum Mill) were studied for their intestinal transport and lipid-lowering effects in Caco-2/HepG2 coculture models. The relative amounts of all phenolic compounds throughout the digestion and intestinal absorption process were determined by UHPLC-Q-Orbitrap mass spectrometry. The digestible and easily transported phenolic compounds in buckwheat extract were identified. Herein, four main phenolic compounds and their metabolites were found on both the apical and basolateral sides of the Caco-2 cell transwell model. The transepithelial transport rates in the Caco-2 cell monolayer were scoparone (0.97) > hydroxycinnamic acid (0.40) > rutin (0.23) > quercetin (0.20). The main metabolism of hydroxycinnamic acid, quercetin, and scoparone in transepithelial transport was found to be methylation. Furthermore, results indicated that triglyceride, low-density lipoprotein cholesterol, total cholesterol, aspartate aminotransferase, and alanine aminotransferase levels in HepG2 cells on the basolateral side of coculture models can be suppressed by 53.64, 23.44, 36.49, 27.98, and 77.42% compared to the oleic acid-induced group (p < 0.05). In addition, the mRNA expression of Fabp4 relative to the control was found to be significantly upregulated (85.82 ± 10.64 to 355.18 ± 65.83%) by the easily transported buckwheat polyphenol components in HepG2 cells (p < 0.01).

Entities:  

Keywords:  coculture models; in vitro digestion; intestinal absorption; lipid-lowering effects; polyphenol extracts from buckwheat

Year:  2020        PMID: 32141744     DOI: 10.1021/acs.jafc.0c00321

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

Review 1.  Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review.

Authors:  Khaled Mohamed Mohamed Koriem
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

2.  First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.

Authors:  Wenjing Liu; Bing Liang; Jun Zeng; Jingsen Meng; Lingyu Shi; Shanbo Yang; Jing Chang; Chao Wang; Xiaokun Hu; Xufu Wang; Na Han; Chenghui Lu; Jiao Li; Congcong Wang; Huanting Li; Renshuai Zhang; Dongming Xing
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.